InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by YOUNG JOHN D, Chief Executive Officer. Director active across 2 companies, notably PFIZER INC. In total, 5 disclosures have been published. Total volume traded: €245k. The latest transaction was filed on 9 March 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations5 total
02,786 shares0
Ordinary Shares
SEC:0001127602-22-008979:0·
€122,2782,800 shares@ €43.67080.0001% mcap100.0% of flow
Common Stock
SEC:0001225208-21-013850·
€122,2782,800 shares@ €43.67080.0001% mcap50.0% of flow
Common Stock
SEC:0001225208-21-013850:0·
08,830 shares0
Common Stock
SEC:0001225208-21-008216·
08,830 shares0
Common Stock
SEC:0001225208-21-008216:0·
5 of 5 declarations
About YOUNG JOHN D
John D. Young is the Group President and CEO at Pfizer Inc and Johnson Controls International plc. He oversees the operations and strategy of both companies, playing a key role in their growth and innovation. His leadership is essential for maintaining market leadership.
